February 22, 2019
Kyowa Pharmaceutical Industry and Mitsubishi Tanabe Pharma said on February 20 that their subsidiary Yoshitomi Yakuhin will copromote Bipresso (quetiapine), a treatment for depressive symptoms associated with bipolar disorder, from March 4. Bipresso, an extended release tablet, contains the same...read more